Skip to content
PubMed This is a summary of 15 peer-reviewed journal articles Updated
Radiation Oncology · Schwannoma

Does Radiosurgery Shrink or Stop Schwannoma Growth?

At a Glance

Stereotactic radiosurgery usually controls a vestibular schwannoma by stopping its growth rather than removing it. The tumor may shrink slowly or stay the same size, and temporary MRI swelling can occur, so doctors use repeat scans over time to judge the response.

The primary goal of stereotactic radiosurgery (SRS) is to stop a benign schwannoma from growing, not to make it disappear completely. In medicine, this goal is called local control [1]. While some tumors do gradually shrink over several years, many remain roughly the same size but become inactive. It is extremely rare for a schwannoma to vanish completely after radiosurgery [2].

Note: The statistics and timelines below are based primarily on research regarding vestibular schwannomas (also known as acoustic neuromas). If you have a schwannoma on a different nerve (such as a spinal or trigeminal schwannoma), ask your doctor how these numbers apply to your specific condition.

How Radiosurgery Affects the Tumor

Unlike traditional surgery, which physically removes the mass, radiosurgery works by delivering highly focused radiation to the tumor [3]. This damages the DNA of the tumor cells, preventing them from replicating [4]. Because schwannomas are slow-growing, the effects of this DNA damage unfold slowly.

Radiosurgery is highly effective at achieving long-term local control. Several large, long-term studies report that SRS successfully stops tumor growth in 90% to 93% of vestibular schwannoma cases at 5 to 10 years after treatment [5][6].

When tracking exactly what happens to the physical volume of the tumor over time, different studies report varying numbers depending on how long patients were followed. In one study tracking patients for an average of 4.5 years:

  • About 47% of tumors eventually showed some degree of shrinkage [2].
  • About 41% remained stable [2].
  • About 12% continued to progress and grow, requiring further intervention [2].

Even if the overall size of the tumor remains stable, the inside of the tumor may be changing. On an MRI, a radiologist might note a loss of contrast enhancement (the tumor absorbs less of the injected MRI dye) or central necrosis (the center of the tumor appearing dark, indicating damaged or dying tissue) [7][4]. While these can be encouraging signs that the tumor is responding to radiation, your care team will interpret them alongside changes in tumor size and your physical symptoms [4][8].

The Swelling Phase: Pseudoprogression

One of the most important things to expect after radiosurgery is that the tumor might actually look larger on early follow-up MRIs. This temporary swelling is called pseudoprogression [9].

In one study of vestibular schwannomas, this temporary swelling occurred in about 44% of cases [9]. It usually begins around one year after treatment and can take up to 3.5 years to reach its peak size [9][10]. Over several years, this swelling typically resolves. In another study focusing specifically on tumors that enlarged after SRS, 83% were found to be experiencing temporary pseudoprogression rather than true, unstoppable growth [11].

Because of this swelling phase, a single MRI showing an enlarged tumor during the first three to four years does not automatically mean the radiosurgery failed [9][12]. Serial imaging—comparing multiple MRIs over time—is often required to tell the difference between temporary swelling and true tumor growth [12].

When to Contact Your Doctor: While swelling on an MRI can be harmless pseudoprogression, swelling can sometimes press on nearby nerves or brain structures. Do not passively wait for your next scheduled scan if you feel worse. Contact your care team promptly if you develop new or worsening symptoms, such as:

  • Severe or worsening headaches, or repeated vomiting
  • Sudden changes in hearing or balance
  • Facial weakness, numbness, or spasms [13]
  • Trouble swallowing, confusion, or marked sleepiness

Long-Term Monitoring and Success

Because radiosurgery leaves the tumor in your body, you will need routine MRI scans for many years to monitor its behavior [14]. The frequency of these scans may decrease over time depending on your tumor’s stability and your doctor’s protocols. Even if a tumor shrinks initially, there is a very rare chance of late regrowth, making long-term surveillance important [15][14].

Success is generally defined as the tumor no longer growing (radiographic control) combined with the management of your symptoms [3]. It is important to know that while SRS can stop the tumor from growing, symptoms you already have (like hearing loss or tinnitus) may not reverse, and can sometimes change independently of the tumor’s size.

Common questions in this guide

What is stereotactic radiosurgery supposed to do to a schwannoma?
Stereotactic radiosurgery is mainly intended to stop a schwannoma from growing, not to remove it. Some tumors gradually shrink, but many remain similar in size while becoming inactive.
How likely is a vestibular schwannoma to stay controlled after SRS?
Long-term studies of vestibular schwannomas report growth control in about 90% to 93% of cases at 5 to 10 years after SRS. These figures may not apply directly to spinal, trigeminal, or other schwannomas, so your doctor should interpret them in light of your tumor's nerve and features.
Why did my schwannoma look bigger on an MRI after radiosurgery?
An early MRI can show temporary enlargement called pseudoprogression, caused by treatment-related swelling rather than unstoppable tumor growth. It often begins around a year after treatment and may take several years to settle, so one enlarged scan does not by itself prove that SRS failed.
How do doctors know whether swelling after SRS is temporary?
Doctors compare a series of MRI scans over time and consider your symptoms instead of judging the result from one scan. Less MRI contrast uptake or damaged tissue in the tumor's center can suggest a response, but these findings must be interpreted with the tumor's size and clinical changes.
Can radiosurgery improve hearing loss or tinnitus caused by a schwannoma?
SRS may control the tumor without reversing symptoms that are already present. Hearing loss and tinnitus may persist or change independently of the tumor's size, so ask your care team what symptom outcomes are realistic for your case.
How long do I need MRI scans after schwannoma radiosurgery?
Routine MRI monitoring is needed for many years because the treated tumor remains in the body and very rarely can regrow later. Scan intervals may become longer when the tumor is stable, based on your doctor's protocol.
Which symptoms after SRS mean I should call my doctor?
Call your care team promptly for severe or worsening headaches, repeated vomiting, sudden changes in hearing or balance, facial weakness, numbness or spasms, trouble swallowing, confusion, or marked sleepiness. These symptoms can reflect pressure on nearby nerves or brain structures and should not wait for the next scheduled scan.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What type of schwannoma do I have, and how closely do the statistics for vestibular schwannomas apply to my case?
  2. 2.If my tumor swells after treatment, how will we determine whether it is pseudoprogression or true continued growth?
  3. 3.What specific MRI signs, such as central necrosis or changes in dye uptake, will you look for to tell if the tumor is responding to radiation?
  4. 4.How often will I need follow-up MRIs in the first five years compared to later in my life?
  5. 5.Which specific new or worsening symptoms should prompt me to call your office immediately rather than waiting for my next scan?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (15)
  1. 1

    Gamma Knife radiosurgery for vestibular schwannomas.

    Kondziolka D, Golfinos JG

    Handbook of clinical neurology 2025; (212()):259-266 doi:10.1016/B978-0-12-824534-7.00007-X.

    PMID: 41052848
  2. 2

    Stereotactic radiosurgery vs. fractionated radiotherapy for large vestibular schwannomas: should FSRT be the preferred treatment?

    Akkus Yildirim B, Beduk Esen CS, Pekgoz OF, et al.

    Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2025; (27(7)):3198-3203 doi:10.1007/s12094-024-03790-0.

    PMID: 39676098
  3. 3

    Salvage radiosurgery following subtotal resection of vestibular schwannomas: does timing influence tumor control?

    Dhayalan D, Perry A, Graffeo CS, et al.

    Journal of neurosurgery 2023; (138(2)):420-429 doi:10.3171/2022.5.JNS22249.

    PMID: 35907189
  4. 4

    Longitudinal Radiographic Outcomes of Vestibular Schwannoma in Single and Fractionated Stereotactic Radiosurgery: A Retrospective Cohort Study.

    Khattab MH, Newman NB, Wharton DM, et al.

    Journal of neurological surgery. Part B, Skull base 2020; (81(3)):308-316 doi:10.1055/s-0039-1692642.

    PMID: 32500007
  5. 5

    Population-Based Study of Stereotactic Radiosurgery or Fractionated Stereotactic Radiation Therapy for Vestibular Schwannoma: Long-Term Outcomes and Toxicities.

    Lo A, Ayre G, Ma R, et al.

    International journal of radiation oncology, biology, physics 2018; (100(2)):443-451 doi:10.1016/j.ijrobp.2017.09.024.

    PMID: 29066124
  6. 6

    Risk analysis of radiosurgery for vestibular schwannoma: Systematic review and comparative study of 10-year outcomes.

    Guy KM, Pace AA, Tsang DS, Volsky PG

    Neuro-oncology advances 2025; (7(1)):vdae191 doi:10.1093/noajnl/vdae191.

    PMID: 39906175
  7. 7

    Gamma Knife Radiosurgery-Induced Acute Facial Palsy in Vestibular Schwannoma: A Case Report.

    Can OB, Ruksen M

    Turkish neurosurgery 2026; (36(4)):620-623 doi:10.5137/1019-5149.JTN.49629-25.2.

    PMID: 42541788
  8. 8

    3D quantitative assessment of response to fractionated stereotactic radiotherapy and single-session stereotactic radiosurgery of vestibular schwannoma.

    Schneider T, Chapiro J, Lin M, et al.

    European radiology 2016; (26(3)):849-57 doi:10.1007/s00330-015-3895-9.

    PMID: 26139318
  9. 9

    Temporal Dynamics of Pseudoprogression After Gamma Knife Radiosurgery for Vestibular Schwannomas-A Retrospective Volumetric Study.

    Breshears JD, Chang J, Molinaro AM, et al.

    Neurosurgery 2019; (84(1)):123-131 doi:10.1093/neuros/nyy019.

    PMID: 29518221
  10. 10

    Tufts Medical Center Experience With Long-Term Follow-Up of Vestibular Schwannoma Treated With Gamma Knife Stereotactic Radiosurgery: Novel Finding of Delayed Pseudoprogression.

    Wage J, Mignano J, Wu J

    Advances in radiation oncology 2021; (6(4)):100687 doi:10.1016/j.adro.2021.100687.

    PMID: 34409200
  11. 11

    A retrospective study demonstrating the growth patterns and the pseudoprogression temporal classification after stereotactic radiosurgery for sporadic vestibular schwannomas.

    El-Shehaby AMN, Reda WA, Abdel Karim KM, et al.

    Scientific reports 2025; (15(1)):18187 doi:10.1038/s41598-025-03095-4.

    PMID: 40415100
  12. 12

    Distinguishing pseudoprogression from true tumor growth after stereotactic surgery in vestibular schwannoma: a volumetric and clinical trajectory analysis.

    Inggas MAM, Apriani S, Hendriansyah L, Wijaya JH

    Radiation oncology (London, England) 2025; (20(1)):185 doi:10.1186/s13014-025-02753-1.

    PMID: 41382184
  13. 13

    Prediction of treatment failure and early identification of tumor progression after Gamma-Knife radiosurgery in vestibular schwannoma: A retrospective cohort study.

    Fabbrocini L, Hurth H, van Eck ATCJ, et al.

    Neuro-oncology advances 2025; (7(1)):vdaf139 doi:10.1093/noajnl/vdaf139.

    PMID: 40756668
  14. 14

    Delayed Vestibular Schwannoma Regrowth Following Shrinkage After Stereotactic Radiosurgery: Implication for Life-Long Surveillance.

    Stapleton E, Crowther JA, Locke R, Kontorinis G

    Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology 2017; (38(2)):260-263 doi:10.1097/MAO.0000000000001280.

    PMID: 28068303
  15. 15

    Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on the Role of Radiosurgery and Radiation Therapy in the Management of Patients With Vestibular Schwannomas.

    Germano IM, Sheehan J, Parish J, et al.

    Neurosurgery 2018; (82(2)):E49-E51 doi:10.1093/neuros/nyx515.

    PMID: 29309637

This page is for informational purposes only and does not constitute medical advice. Your treating team should interpret your MRI results, symptoms, and treatment response for your specific schwannoma.

Get notified when new evidence is published on Benign schwannoma.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.